PASIREOTIDE for Thyroid cancer: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 6 adverse event reports in the FDA FAERS database where PASIREOTIDE was used for Thyroid cancer.
Most Reported Side Effects for PASIREOTIDE
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Hyperglycaemia | 252 | 13.2% | 7 | 100 |
| Diabetes mellitus | 224 | 11.7% | 7 | 40 |
| Blood glucose increased | 219 | 11.5% | 4 | 71 |
| Diarrhoea | 160 | 8.4% | 6 | 34 |
| Fatigue | 160 | 8.4% | 7 | 66 |
| Nausea | 150 | 7.9% | 9 | 45 |
| Headache | 139 | 7.3% | 3 | 51 |
| Drug ineffective | 132 | 6.9% | 8 | 28 |
| Dizziness | 100 | 5.2% | 3 | 45 |
| Off label use | 94 | 4.9% | 17 | 38 |
| Vomiting | 87 | 4.6% | 7 | 44 |
| Weight decreased | 82 | 4.3% | 1 | 41 |
| Asthenia | 80 | 4.2% | 2 | 40 |
| Blood pressure increased | 78 | 4.1% | 1 | 29 |
| Abdominal pain | 70 | 3.7% | 0 | 33 |
Other Indications for PASIREOTIDE
Acromegaly (737)
Pituitary-dependent cushing's syndrome (486)
Product used for unknown indication (246)
Cushing's syndrome (119)
Gigantism (99)
Pituitary tumour (43)
Pituitary tumour benign (37)
Off label use (31)
Hypoglycaemia (24)
Neuroendocrine tumour (20)
Other Drugs Used for Thyroid cancer
LENVATINIB (2,668)
CABOZANTINIB S-MALATE (1,615)
VANDETANIB (591)
DABRAFENIB (583)
TRAMETINIB DIMETHYL SULFOXIDE (482)
SORAFENIB (399)
LEVOTHYROXINE (299)
PAZOPANIB (264)
PRALSETINIB (199)
CABOZANTINIB (125)